Immunesenescence and inflammaging: A contributory factor in the poor outcome of the geriatric trauma patient by Hazeldine, Jon et al.
 
 
University of Birmingham
Immunesenescence and inflammaging: A
contributory factor in the poor outcome of the
geriatric trauma patient
Hazeldine, Jon; Lord, Janet M.; Hampson, Peter
DOI:
10.1016/j.arr.2015.10.003
License:
Creative Commons: Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)
Document Version
Peer reviewed version
Citation for published version (Harvard):
Hazeldine, J, Lord, JM & Hampson, P 2015, 'Immunesenescence and inflammaging: A contributory factor in the
poor outcome of the geriatric trauma patient', Ageing Research Reviews, vol. 24, no. B, pp. 349-357.
https://doi.org/10.1016/j.arr.2015.10.003
Link to publication on Research at Birmingham portal
Publisher Rights Statement:
Checked for eligibility: 17/02/2016
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Mar. 2020
Accepted Manuscript
Title: Immunesenescence and inflammaging: A contributory
factor in the poor outcome of the geriatric trauma patient
Author: Jon Hazeldine Janet M. Lord Peter Hampson
PII: S1568-1637(15)30028-3
DOI: http://dx.doi.org/doi:10.1016/j.arr.2015.10.003
Reference: ARR 613
To appear in: Ageing Research Reviews
Received date: 11-8-2015
Revised date: 12-10-2015
Accepted date: 13-10-2015
Please cite this article as: Hazeldine, Jon, Lord, Janet M., Hampson,
Peter, Immunesenescence and inflammaging: A contributory factor in the
poor outcome of the geriatric trauma patient.Ageing Research Reviews
http://dx.doi.org/10.1016/j.arr.2015.10.003
This is a PDF file of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript.
The manuscript will undergo copyediting, typesetting, and review of the resulting proof
before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that
apply to the journal pertain.
Immunesenescence and inflammaging: a contributory factor in the poor outcome of the 
geriatric trauma patient 
Jon Hazeldine
1
, Janet M. Lord
1
, Peter Hampson
1,2*
 P.Hampson@bham.ac.uk 
1
NIHR Surgical Reconstruction and Microbiology Research Centre, School of Immunity and 
Infection, Birmingham University Medical School, Birmingham, B15 2TT. 
2
Healing Foundation Centre for Burns Research, Queen Elizabeth Hospital, Birmingham, 
B15 2WB, UK. 
*
Correspondence author at: School of Immunity and Infection, Birmingham University 
Medical School, Birmingham, B15 2TT, UK, Tel.: +44 121 371 3264, Fax: +44 121 371 
3203. 
  
Highlights 
 Aging is associated with a dysregulated immune and inflammatory response. 
 Older adults have worse outcome post-trauma, including increased infection rates. 
 Impaired immunity and delayed resolution of inflammation may underlie poor outcome. 
 A detailed understanding of the mechanism(s) responsible has yet to be determined. 
  
Abstract 
Compared to younger patients, traumatic injury in older patients is associated with increased 
mortality and a range of adverse outcomes such as higher rates of infectious episodes, longer 
length of hospital stay and poor functional outcome at follow up. Data emerging from human 
and murine-based studies suggest age-related changes in immune function, collectively 
termed immunesenescence, and the chronic sub-clinical systemic inflammatory state of older 
adults, termed inflammaging, may contribute to these poor outcomes. Here, we review the 
findings of these studies, whose results demonstrate that the geriatric trauma patient elicits an 
immune response to injury that is distinct to that of younger adults, being characterised by 
reduced immune cell activation, impaired function and abnormal haematopoiesis, defects that 
are accompanied by an altered inflammatory response that fails to return to a homeostatic 
baseline in the days following injury. Although considerable evidence is accumulating that 
demonstrates clear and significant age-related differences in the immune and inflammatory 
response to traumatic injury, our current understanding of the mechanism(s) that underlie 
these changes is limited. Future studies that provide a mechanistic explanation for the unique 
immune and inflammatory response of older adults to traumatic injury are therefore essential 
if we are to determine whether manipulation of the immune system has potential as a future 
therapeutic strategy by which to improve the outcome of the geriatric trauma patient. 
Keywords: Ageing; innate immunity; immunesenescence; infection; trauma. 
  
1.0 Introduction 
Recent advancements in medical care and public health policies, as well as improvements in 
socio-economic status mean we are now living longer than ever before. By 2050, it is 
estimated that the proportion of older adults (aged 60 years and over), who accounted for               
9.2 and 11.7 percent of the global population in 1990 and 2013 respectively, will constitute 
21.1 percent of the total world’s population by 2050 (United Nations World Population 
Healthy Ageing Report 2013). In this section of society, traumatic injury is a major cause of 
morbidity and mortality. Compared to younger adults, geriatric trauma patients exhibit 
increased mortality rates (Nacionales et al. 2015;Newell et al. 2009;Taylor et al. 
2002;Vanzant et al. 2015), a longer length of hospital stay (McKevitt et al. 2003;Taylor et al. 
2002;Vanzant et al. 2015), higher rates of infectious complications (Butcher et al. 
2003;Vanzant et al. 2015), a greater need for rehabilitation (McKevitt et al. 2003;Nacionales 
et al. 2015;Shinoda-Tagawa and Clark 2003;Vanzant et al. 2015) and worse functional 
outcomes (Mosenthal et al. 2002) following mild and severe traumatic injury, resulting in 
greater resource usage and management costs (MacKenzie et al. 1990;Newell et al. 
2009;Ross et al. 1989). With the shift that is anticipated to occur in global population 
demographics in the coming years (United Nations World Population Healthy Ageing Report 
2013) and the fact that older adults represent an increasing proportion of trauma centre 
admissions (Clark and Chu 2002;Hannan et al. 2004;Shinoda-Tagawa and Clark 2003), 
geriatric trauma is expected to become a major future public healthcare issue.  
Recently, in an effort to improve clinical decision making and management of the geriatric 
trauma patient, prospective and retrospective studies have been conducted with the aim of 
developing robust scoring systems capable of predicting patient outcome (Brooks et al. 
2014;Joseph et al. 2014a;Joseph et al. 2014b). From these studies, a measure of frailty, 
defined by a series of variables that exhibit strong association for unfavourable discharge 
such as existing co-morbidities, daily activity patterns and nutrition (Joesph et al. 2014a)  has 
emerged as a strong independent predictor of both mortality and long-term hospitalisation 
following traumatic injury, proving to be superior to both age and injury severity as a 
predictor of patient outcome (Joseph et al. 2014b).  However, despite these studies providing 
novel predictive models that have the potential to influence patient care, a greater 
understanding of the mechanism(s) that underlie the poor outcomes of the geriatric trauma 
patient is needed. Reduced physiological reserve and pre-existing co-morbidities are often 
cited as being primarily responsible. However, independent of injury severity and after 
adjustment for co-morbidities, older adults still exhibit significantly worse prognosis post 
trauma when compared to their younger counterparts (Bruijns et al. 2013;Jones et al. 2014).  
Physiological ageing is associated with remodelling of the immune system, a phenomenon 
termed immunesenescence. Evident in both the innate and adaptive arms of the immune 
system (Table 1), immunesenescence encompasses the age-related changes that occur in the 
composition, phenotype and function of the peripheral immune cell pool as well as the 
chronic sub-clinical systemic inflammatory state of older adults, termed inflammaging, which 
is characterised by elevated levels of serum pro-inflammatory cytokines and reduced levels of 
anti-inflammatory cytokines (Bartlett et al. 2012;Stowe et al. 2010;Wei et al. 1992). 
Following both mild and severe traumatic injury, older adults suffer from an increased 
incidence and severity of nosocomial infection (Blot et al. 2014;Bochicchio et al. 
2001;Butcher et al. 2003;Vanzant et al. 2015), which has adverse effects on outcome in 
respect of increased mortality rates and longer length of hospital stay (Brusselaers et al. 
2010; Colohan2010;Richards et al. 2013). These observations coupled with the future 
changes that are expected in population demographics (United Nations World Population 
Healthy Ageing Report 2013) has led a number of groups to investigate the impact of age on 
the immune and inflammatory response to traumatic injury. Here, we review the findings of 
these studies, which taken together, suggest that by exacerbating the changes in immune 
function that occur as a direct consequence of traumatic injury, immunesenescence 
contributes to the poor outcome of the geriatric trauma patient by increasing their 
susceptibility to infection and subsequent mortality. 
2.0 The impact of immunesenescence and inflammaging on the immune and 
inflammatory response to traumatic injury in the geriatric trauma patient 
2.1 Immunesenescence 
Through two observational longitudinal studies in the setting of mild traumatic injury, 
defined as an injury severity score (ISS) <15, we were the first group to comprehensively 
investigate whether immunesenescence could influence patient susceptibility to infection post 
trauma (Butcher et al. 2003;Butcher et al. 2005). Focussing exclusively upon the 
microbicidal function of neutrophils, which serve as the first line of defence against 
pathogenic infection, we found reactive oxygen species (ROS) production by neutrophils 
isolated from older adults within 24 hours of sustaining a fractured neck of femur as well as 
five weeks post injury was significantly reduced when compared to ROS generation by 
neutrophils obtained from healthy older adults (Butcher, et al. 2003;Butcher et al. 2005). 
Importantly, when the cohort was split into those elderly hip fracture (HF) patients who went 
on to develop infection and those who remained infection free during follow-up, ROS 
production was significantly lower in the former group (Butcher et al. 2003). In contrast, in a 
cohort of young trauma patients that had sustained a single limb fracture, none of whom 
reported post traumatic infection, neutrophil ROS generation was comparable to that of 
young healthy controls (Butcher et al. 2003). Thus, these two studies were the first to suggest 
that age and not the traumatic injury per se was responsible for driving the aberrant 
neutrophil function observed in elderly HF patients and the subsequent development of post 
traumatic complications. Following on from this work, Baehl et al (Baehl et al. 2015) have 
recently shown neutrophil ROS generation remains suppressed for up to six months post HF 
in older adults, a defect they attributed to reduced activation of p47
phox
, a critical subunit of 
the ROS generating enzyme nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 
(Baehl et al. 2015). Accompanying this reduction in ROS generation was a short-term 
impairment in the ability of neutrophils to phagocytose immunoglobulin (Ig)-opsonised 
Escherichia coli (E.coli) (Baehl et al. 2015).  The group also observed during this time-period 
a significant reduction in the surface density of CD16, an Fcγ receptor that facilitates 
neutrophil recognition of Ig-coated pathogens and whose expression we have shown is 
reduced during “healthy” ageing (Butcher et al. 2001). It may be therefore, that akin to our 
findings with ROS generation (Butcher et al. 2003;Butcher et al. 2005), immunesenescence 
exacerbates the effect of mild trauma on the phagocytic activity of neutrophils via a reduction 
in CD16 expression.   
Alongside the more renowned defensive mechanisms of ROS production and phagocytosis, 
activated neutrophils release into the extracellular environment their nuclear DNA decorated 
with a range of granule-derived proteases and peptides (Brinkmann et al. 2004). Termed 
neutrophil extracellular traps (NETs), these structures are considered the “last resort” in 
neutrophil anti-microbial defence and play a key role in preventing the dissemination of 
invading pathogens (Meng et al. 2012; Yipp et al. 2012). Two studies have recently 
demonstrated a significant impairment in NET generation during “healthy ageing”. Using 
murine neutrophils, Tseng et al found in vitro NET formation by neutrophils from young 
mice was approximately 2.5-fold higher than that of neutrophils from aged mice following 
treatment with either the diacylglycerol mimetic phorbol 12-myristate 13-acetate (PMA) or 
methicillin-resistant Staphylococcus aureus (S.aureus) (Tseng et al. 2012). Furthermore, in an 
in vivo model of MRSA infection, whilst observing extracellular DNA networks that 
contained entrapped bacteria in tissue extracted from young mice, the group found no 
evidence of any NET-derived extracellular DNA in areas of infected skin tissue in aged mice 
(Tseng et al. 2012). In line with these observations, we recently demonstrated that human 
ageing is also accompanied by an impairment in NET production, with tumour-necrosis 
factor alpha-primed neutrophils from older adults (≥65 years) generating significantly fewer 
NETs upon IL-8 and LPS stimulation when compared to those from younger adults                       
(≤35 years) (Hazeldine et al. 2014). To date, only one study has examined NET production in 
the context of geriatric trauma. Comparing PMA-induced NET generation by neutrophils 
isolated from severely-injured young (≤65 years) and old  (≥65 years) trauma patients with a 
group of age-matched healthy controls, Itagaki et al observed similar NET production by 
neutrophils isolated from young trauma patients and their controls, suggesting no detrimental 
effect of trauma on this neutrophil function (Itagaki et al. 2015). In contrast, PMA-induced 
NET release by neutrophils from traumatically-injured older adults was negligible, mirroring 
the response of neutrophils isolated from healthy older adults (Itagaki et al. 2015). Thus, as 
outlined above for ROS production (Butcher et al 2003), it appears that age and not trauma 
per se is responsible for the aberration in NET formation in the geriatric trauma patient. 
Severe blunt traumatic injury (ISS > 15) in older adults has recently been shown to elicit a 
unique genomic response in peripheral leukocytes. As part of a prospective observational 
trial, Vanzant and colleagues (Vanzant et al. 2015) characterised and compared the 
transcriptomic responses of circulating neutrophils isolated from severely injured young (<55 
years) and older (>55 years) adults with evidence of haemorrhagic shock and observed 
significant age-related alterations in gene expression (Vanzant et al. 2015). Restricting their 
analysis to those patients with complicated outcome (defined as a stay in intensive care for 
longer than 14 days with evidence of ongoing organ dysfunction or death) the group reported 
that in the acute phase post injury (12 hours and 1 day), gene expression patterns were 
significantly less perturbed in neutrophils from older donors when compared to their younger 
counterparts (Vanzant et al. 2015). However, at day 4 post injury, a time-point at which gene-
fold changes in neutrophils from younger patients had begun to return to baseline levels, 
neutrophils from older adults still demonstrated significant gene alterations when compared 
to healthy controls. Detailed analysis revealed these alterations were in genes involved in 
decreased chemotaxis of neutrophils (e.g. interleukin-8), up-regulation of myeloid derived 
suppressor cells (e.g. arginase 1), increased inflammation (e.g. matrix metalloprotease 8 and 
9) and decreased innate and adaptive immunity (Vanzant et al. 2015). Interestingly, these 
alterations in gene expression mirror functional and compositional observations that have 
been reported to occur during “healthy” ageing, with recent immune gerontological studies 
reporting ageing to be associated with decreased neutrophil chemotaxis (Sapey et al. 2014) 
and an increased frequency of circulating myeloid derived suppressor cells (Verschoor et al. 
2013), which occur alongside the chronic sub-clinical systemic inflammatory state of older 
adults (Stowe et al. 2010;Wei et al. 1992).Thus, the prolonged neutrophil transcriptome 
response observed by Vanzant et al (Vanzant et al. 2015) in injured older adults may be a 
consequence of trauma-induced changes superimposed on the background of age-related 
immunesenescence. 
Following thermal injury, mortality rates are greater in aged mice when compared to young 
mice and are accompanied by a greater degree of immune suppression (Kovacs et al. 
2004a;Kovacs et al. 2002;Kovacs et al. 2004b). Following a 15% total body surface area 
(TBSA) burn, aged mice exhibit impaired delayed type hypersensitivity (DTH) responses, 
significantly reduced immune cell proliferation and a greater shift in the T helper (TH)-1-TH-2 
cytokine profile when compared to the response of young mice subjected to injuries of 
comparable size and depth (Kovacs et al. 2004a;Kovacs et al. 2004b). Interestingly, estrogen 
supplementation in aged mice prior to injury partially restored both the thermal-induced 
defective DTH response and aberrant TH1-TH2 cytokine profile, which was accompanied by a 
28% increase in survival rates (Kovacs et al. 2004a;Kovacs et al. 2004b). Despite the success 
of these studies, no study to our knowledge has examined whether estrogen supplementation 
post burn can elicit the same beneficial effects upon immune function and survival rates.   
In murine models of polytrauma and subsequent Pseudomonas pneumonia infection, 
Nacionales et al (Nacionales et al. 2015) have shown aged mice exhibit increased mortality 
rates when compared to their younger counterparts. Interestingly, no evidence of any age-
related differences in mortality rates were found following polytrauma alone, demonstrating 
that infection is driving the higher rates of mortality amongst aged mice in this combined 
model of trauma and secondary infection (Nacionales et al. 2015). Proposing a role for 
immunesenescence in this poor outcome, the group studied the microbicidal activity of lung-
resident neutrophils and reported a significant age-related impairment in phagocytosis, a 
defect they traced back to the level of the transcriptome, where during the acute phase of 
trauma it was found that aged mice failed to up-regulate genes involved in phagocytosis as 
efficiently as young mice (Nacionales et al. 2015). Additional observations made in this 
study were that there were significantly fewer short-term hematopoietic stem cells (HSCs) in 
the bone marrow (BM) of aged mice post trauma and that lineage
-
 sca-1
+
 c-kit
+
 cells (LSKs) 
isolated from aged BM exhibited impaired proliferation (Nacionales et al. 2015). Again, as 
with lung-resident leukocytes, age-related differences were observed at the level of the HSC 
transcriptome, with those obtained from elderly mice post trauma failing to upregulate 
expression of innate immunity genes related to chemotaxis and toll-like receptors as 
efficiently as HSCs from their younger injured counterparts (Nacionales et al. 2015). Based 
on these latter findings, it has been proposed that following severe trauma, failure of aged 
HSCs to undergo adequate rapid myelopoiesis culminates in the release into the circulation of 
granulocytes with suboptimal function, thereby leaving aged mice susceptible to secondary 
infections and ultimately death (Nacionales et al. 2015).  
A common complication in hospitalised older adults is the development of sepsis, with nearly 
60% of sepsis cases occurring in patients aged 65 years and over, which in the setting of 
critical care is associated with worse clinical outcome (Mann et al. 2012;Martin et al. 2006). 
The results of recent human (Inoue et al. 2014;Inoue et al. 2013) and murine (Gentile et al. 
2014;Nacionales et al. 2014) based studies suggest this susceptibility is attributable in part to 
age-related defects in innate (Gentile et al. 2014;Nacionales et al. 2014) and adaptive (Inoue 
et al. 2014;Inoue et al. 2013) immunity. As early as day one post septic insult, both 
monocytes and neutrophils isolated from aged mice exhibit impaired ROS generation and 
phagocytosis when compared to the response of cells from young septic mice (Nacionales et 
al. 2014). Analysis of blood leukocyte gene expression has revealed an attenuated early 
genomic response in aged mice with the up-regulation of genes relating to neutrophil-
mediated immunity, chemotaxis and chemokine binding significantly lower in aged septic 
mice, suggesting that the early aberration observed in immune function can be explained at 
the level of the leukocyte transcriptome (Nacionales et al. 2014). Interestingly, and in line 
with the abovementioned human study in severely injured patients with haemorrhagic shock 
(Vanzant et al. 2015), gene expression in septic aged mice fails to return to homeostasis at 
day 3 post septic insult, which is in contrast to young septic mice, whose leukocyte gene 
profiles are near comparable to those of healthy young controls (Nacionales et al. 2014). This 
sustained response was suggested to reflect the inability of the aged immune system to 
efficiently clear the microbial infection, culminating in an ongoing infectious insult that 
elicited continual immune cell stimulation and gene upregulation (Nacionales et al. 2014).  
If immunesenescence exacerbates trauma-induced changes in immune function and thereby 
contributes to the poor outcome of the geriatric trauma patient by increasing their 
susceptibility to infection, is it amenable to therapeutic targeting for patient benefit? To 
address this question, we must first understand the mechanism(s) that underlie the more 
severe immunoparesis in the older trauma patient. It is well established that ageing is 
associated with a reduction in the circulating levels of DHEA (Orentreich et al. 1992), an 
immune enhancing steroid hormone that counteracts the potent immune suppressive 
properties of corticosterone, whose production is maintained with age (Hazeldine et al. 
2010). Thus, healthy older adults possess a raised circulating cortisol:DHEAS ratio 
(Orentreich et al. 1992). Following traumatic injury, corticosterone levels rise, whilst DHEA 
levels are unaltered (Wade et al. 1988). Thus, given the increased cortisol:DHEAS ratio that 
occurs naturally with age, one would expect trauma in older adults would result in a more 
severe corticosterone excess than would be observed in the younger trauma patient, resulting 
in a state of peripheral immune suppression. In line with this hypothesis, we found the 
cortisol:DHEAS ratio in elderly HF patients was significantly higher than that measured in 
healthy elderly subjects and a cohort of young orthopaedic trauma patients (Butcher et al. 
2005). Moreover, we noted that the ratio was significantly higher in those individuals who 
subsequently developed an infection in the 6 weeks following injury, suggesting a raised 
cortisol:DHEAS ratio had increased patient susceptibility to infection, presumably via 
reducing the microbicidal activity of circulating neutrophils (Butcher et al. 2005). As in vitro 
studies have shown DHEAS can prevent cortisol-mediated inhibition of formyl-methionine-
leucine-phenylalanine (fMLP)-induced ROS production by primed neutrophils (Butcher et al. 
2005), DHEA replacement could potentially reduce infection risk in the elderly trauma 
patient by counteracting trauma-induced glucocorticoid excess, thereby creating an 
environment that favours immune enhancement over immune suppression (Butcher et al. 
2003;Butcher et al. 2005;Butcher and Lord 2004). 
2.2 Inflammaging  
Numerous studies in healthy subjects have demonstrated that advanced age is associated with 
a hyper-inflammatory state. Termed “inflammaging”, this state is characterised by an age-
related chronic low grade increase in basal circulating levels of a number of pro-
inflammatory cytokines, most notably interleukin (IL)-6 (Bartlett et al. 2012;Stowe et al. 
2010;Wei et al. 1992) and tumor necrosis factor-alpha (TNF-α) (Bartlett et al. 2012;Paolisso 
et al. 1998;Stowe et al. 2010). Importantly, “inflammaging” is recognised as an important 
pathogenic factor in the development of age-related pathologies including type-2 diabetes 
(Paolisso et al. 1998) and cardiovascular disease (Bruunsgaard et al. 2000;Jenny et al. 
2002;Libby et al. 2010), and has also been shown to be a strong predictor of all-cause 
mortality risk in the elderly in a number of longitudinal cohort studies (Bruunsgaard et al. 
2003;Harris et al. 1999;Reuben et al. 2002). 
Traumatic injury leads to a systemic inflammatory response syndrome (SIRS), characterised 
by an acute increase in serum levels of pro-inflammatory cytokines such as IL-1, IL-6, and 
TNF-α (Bone et al. 1992). Importantly, circulating levels of pro-inflammatory cytokines 
following traumatic injury are associated with mortality. For example, in a cohort of 230 
patients who had sustained a thermal injury, Jeschke and colleagues (Jeschke et al. 2014) 
showed that individuals who did not survive their injury had significantly higher levels of IL-
6, IL-8 and granulocyte colony stimulating factor (G-CSF) compared to survivors, and 
similar findings have been made in the case of TNF-α (Marano et al. 1990;Zhang et al. 
1998). In addition, in a cohort of 29 intensive care unit patients with severe sepsis or septic 
shock, IL-6, IL-8 and MCP-1 levels were significantly higher in those patients with a fatal 
outcome (Andaluz-Ojeda et al. 2012). SIRS is accompanied by a compensatory anti-
inflammatory response syndrome (CARS) (Xiao et al. 2011) designed to counteract the 
ongoing inflammation. However, CARS can lead to a state of immune suppression, including 
a reduction in neutrophil function (Parment et al. 2007) predisposing the patient to infections 
and sepsis. Indeed, IL-10 levels have been shown to be significantly higher in those patients 
with poor outcome (Andaluz-Ojeda et al. 2012;Jeschke et al. 2014). 
Given that advanced age is accompanied by elevated circulating basal levels of pro-
inflammatory cytokines, and pro-inflammatory cytokine levels are associated with 
complicated outcome post-trauma, it is reasonable to suggest that the SIRS response may be 
exaggerated in older patients and that this may, at last in part, underlie the poor prognosis of 
the elderly trauma patient. In support of this idea, work from the Kovacs laboratory has 
shown that similar to elderly humans, aged mice have increased mortality in response to burn 
injury (Kovacs et al. 2002). In a subsequent study, where mice were subjected to a 15% 
TBSA burn, the group found that aged mice had double the serum levels of IL-6 when 
compared to young mice (Kovacs et al. 2004b). Furthermore, when old mice were given 
estrogen replacement therapy, which began 7 days prior to burn injury, diminished IL-6 
release was observed post-burn, which was accompanied by improved survival rates (Kovacs 
et al. 2004b). Similar observations of elevated cytokine levels in the aged trauma patient have 
been made following the relatively mild trauma of HF. In a recent study, Vester et al (Vester 
et al. 2014) demonstrated that old (>70 years) HF patients had elevated serum levels of IL-6 
on admission compared to old healthy controls, which increased further following surgery. In 
contrast, IL-6 levels were not elevated above the levels seen in healthy controls for young 
(<50 years) patients with long bone fractures, nor were they elevated following surgery 
(Vester et al. 2014). Baëlh and colleagues also documented increased levels of pro-
inflammatory cytokines in old patients following HF, including IL-6 and TNF-α (Baehl et al. 
2015). Interestingly, the group found that the levels of TNF-α were still significantly elevated 
6 months post-fracture, suggesting an inability of old hip fracture patients to resolve the 
inflammation (Baehl et al. 2015). 
In contrast to the aforementioned studies, murine models of polytrauma, in which mice are 
subjected to haemorrhagic trauma and long bone fracture, have yielded conflicting results. 
Nacionales et al (Nacionales et al. 2015) found no difference in serum levels of IL-6 or TNF-
α between old and young mice 1 day after polytrauma. In fact, the data showed a trend 
towards reduced levels in the old mice although this was not statistically significant 
(Nacionales et al. 2015). Published by the same group, data from the Inflammation and the 
Host Response to Injury Collaborative Program, has demonstrated a similar pattern in human 
severe trauma. In a cohort of 244 patients who had suffered blunt trauma and were in 
haemorrhagic shock, the authors found that old (≥55 years) patients with complicated 
outcomes (ICU hospitalization for longer than 14 days with evidence of ongoing organ 
dysfunction, or death) had decreased plasma cytokine and chemokine (IL-6, IL-8, IL-10, 
TNF-α and monocyte-chemoattractant protein-1) levels when compared to young (<55 years) 
patients with complicated outcomes (Vanzant et al. 2015). Taken together, the results of these 
two studies suggest that “inflammaging” does not lead to an exaggerated systemic 
inflammatory response to injury in the elderly. These studies did suggest however, that the 
inflammatory response in the old takes longer to resolve to baseline levels when compared to 
the young. Interestingly, a study of 50 critically ill blunt trauma patients found significantly 
lower plasma IL-6 and IL-10 levels in geriatric patients compared to young patients, and the 
development of a secondary infection was associated with lower presenting IL-6 and IL-10 
levels in the geriatric group (Ottinger et al. 2014). 
Inter study differences in the severity and mechanisms of traumatic injury, as well as the 
different age cut-offs used to define a geriatric trauma patient are likely to have contributed to 
the conflicting observations described above. Directly comparing data obtained from murine 
and human models of trauma may also be a source of variation given the difficulty that exists 
in replicating the type, severity and clinical course of human injury in mice as well as the 
species differences in circulating leukocyte populations. Indeed, at the genomic level it has 
been suggested that murine models of burn and trauma poorly mimic the human condition 
(Gentile et al. 2014b; Seok et al. 2013). However, this has recently been challenged by Takao 
and colleagues who reported strong similarities in the genomic response of mice and humans 
following both thermal and traumatic injury (Takao et al . 2015). Thus the debate continues 
as to how suitable murine models are at recapitulating in its entirety the human response to 
traumatic injury.  
Despite the reported differences in respect of the inflammatory response elicited by young 
and old trauma patients, the general consensus is that older adults elicit a sustained 
inflammatory response that takes longer to resolve to baseline levels, leading to prolonged 
immune suppression and increased susceptibility to infection. Further studies are required in 
order to better understand the age-related changes in the inflammatory response to injury, and 
the mechanism(s) underlying its persistence, as this may provide therapeutic targets which 
would allow a stratified treatment strategy in the geriatric trauma patient.  
3.0 Impaired resolution of inflammatory responses and accumulation of damage 
associated molecular patterns (DAMPs): an underlying cause of immunoparesis in the 
geriatric trauma patient?  
3.1 The effect of DAMPs on innate immune cells 
The systemic inflammatory response syndrome that occurs following traumatic injury is 
thought to be initiated in part by damage associated molecular patterns (DAMPs). Actively 
secreted by immune cells and released from damaged and necrotic tissue (Gardella et al. 
2002;Kaczmarek et al. 2013), nuclear and mitochondrial DAMPs have been shown in vitro 
and in vivo to trigger a range of immune responses, which include: (i) neutrophil ROS 
production, degranulation, chemokine secretion and extracellular trap generation (Hazeldine 
et al. 2015;Itagaki et al. 2015), (ii) pro-inflammatory cytokine production (Collins et al. 
2004) and (iii) monocyte activation (Crouser et al. 2009). This immune cell activation is 
driven through pattern recognition receptors (PPR) such as TLR-9 in the case of 
mitochondrial DNA and formyl peptide receptors (FPR) in the case of mitochondrial-derived 
formyl peptides (Zhang, 2010). The fact that these DAMPs bind to the same PRRs as 
pathogen-associated molecular patterns (PAMPs) is attributable to structural similarities. For 
example, the CpG repeats that define mitochondrial DNA are also present in bacterial DNA 
and bind to TLR-9. 
3.2 DAMP induced immune tolerance 
Human ageing has recently been reported to be associated with marked elevations in 
circulating DAMPs, with plasma levels of the mitochondrial DAMP, mtDNA, found to be 
significantly higher in healthy older adults (Itagaki et al. 2015;Pinti et al. 2014). In the 
context of physiological ageing, an age-related accumulation of DAMPs has been proposed 
as a factor driving the chronic low-grade inflammatory state of healthy older adults 
(Kapetanovic et al. 2015). Interestingly, as with healthy ageing, plasma levels of mtDNA 
have been found to be significantly higher in the geriatric trauma patient when compared to 
the levels measured in younger trauma subjects matched for injury severity (Itagaki et al. 
2015). Whether simply an additive effect of trauma and age-induced DAMP release or the 
result of other mechanisms such as reduced clearance rates, could an increased amount of 
circulating DAMPs contribute to the more severe immunoparesis experienced by the 
geriatric trauma patient? Results of a handful of recent studies suggest this could be the case. 
Due to structural similarities, N-formyl peptides released from ruptured mitochondria post 
trauma activate the same intracellular signalling cascades as the bacterial peptide fMLP. Prior 
exposure to fMLP has been shown to markedly suppress the chemotactic response of 
neutrophils upon secondary stimulation (Li et al. 2015). Based on this result and ex vivo data 
showing neutrophil chemotaxis is significantly reduced post trauma (Li et al. 2015), the 
phrase “DAMP-induced tolerance” has been coined, which proposes that circulating 
mitochondrial-derived DAMPs released following traumatic injury may tolerise neutrophils 
to subsequent pathogenic danger signals (Li et al. 2015).  Thus, in the context of the geriatric 
trauma patient, it is conceivable that not only would the levels of circulating DAMPs be 
higher in the immediate aftermath of trauma (Itagaki et al. 2015) but such levels would be 
retained for a longer period of time given the apparent age-related impairment in DAMP 
clearance (Itagaki et al. 2015;Pinti et al. 2014). Consequently, the tolerising effects of 
DAMPs could be one factor underlying both the short (Butcher et al. 2003;Butcher et al. 
2005) and long (Baehl et al. 2015) term suppression of neutrophil microbicidal function that 
has been reported in the aged trauma patient, leaving them at risk of subsequent infectious 
episodes. In addition to influencing the functional activity of neutrophils, DAMPs have been 
found to: (i) induce endotoxin tolerance in human monocytes (Fernandez-Ruiz et al. 2014), 
(ii) drive the functional exhaustion of murine monocytes (Liesz et al. 2015) and (iii) induce a 
state of systemic lymphopenia in vivo (Liesz et al. 2015). Thus, a higher abundance of 
circulating DAMPs could be one mechanism that contributes to the significantly impaired 
innate (Baehl et al. 2015;Butcher et al. 2003;Butcher et al. 2005) and adaptive (Kovacs et al. 
2004a;Kovacs et al. 2004b) immune responses of the geriatric trauma patient. Interestingly, a 
recent study by Yao et al found that estrogen treatment 15 minutes following a 40% TBSA 
burn injury, was able to protect rats from trauma-induced cardiac damage, and that this effect 
was the result of decreased mtDNA release (Yao et al. 2014). This data may also explain the 
mechanism underlying the protective effects (reduced IL-6 release and mortality) of estrogen 
treatment in murine models of burn injury, as published by the Kovacs laboratory (Kovacs et 
al. 2004b). If it is the case that DAMPs are at least in part responsible for the reduction in 
neutrophil function seen post injury, then could this provide a potential therapeutic avenue to 
help reduce infections post-trauma? Whilst this is possible in theory at least, a better 
understanding of kinetics of DAMP release post-trauma is required to ensure that preventing 
the DAMP induced tolerance of immune cells can be achieved, without unnecessarily 
supressing the immune response that may be required to deal with the immediate aftermath of 
the injury itself.  
3.3 Do elevated circulating DAMP levels drive sustained inflammation and immunoparesis in 
old trauma patients? 
Transcriptomic analysis of neutrophils isolated from severely injured patients with 
haemorrhagic shock has revealed advanced age is associated with a unique genomic response 
(Vanzant et al. 2015). Of interest, it was found that at day 4 post injury, a time-point where 
gene-fold changes in neutrophils from younger patients had begun to return to baseline levels, 
neutrophils from older adults still demonstrated significant alterations in genes related to 
decreased chemotaxis, increased inflammation and decreased innate immunity when 
compared to healthy controls (Vanzant et al. 2015). Interestingly, evidence from a murine 
model of burn injury suggests that following a traumatic insult, resolution of inflammation is 
attenuated with age. Following a 15% TBSA, full thickness burn, Nomellini et al (Nomellini 
et al. 2008) measured inflammatory cell accumulation in the lungs at 24 hours post injury and 
found that whilst the number of neutrophils remained significantly elevated in aged, burn-
injured mice when compared with sham controls, neutrophil numbers were comparable in the 
lungs of young burn-injured and non-injured mice (Nomellini et al. 2008), suggesting an age-
related impairment in neutrophil clearance. If replicated in humans, one can envisage how 
failure to clear apoptotic neutrophils would result in cellular necrosis and the release of 
DAMPs into the extracellular environment. This would result in sustained stimulation of 
neighbouring cells, which could explain both the transcriptome data that has revealed gene 
expression in aged leukocytes fails to return to baseline as quickly as leukocytes from 
younger subjects (Vanzant et al. 2015), as well as the in vitro and in vivo immune tolerance 
that has been observed in aged mice and humans post injury (Baehl et al. 2015;Butcher et al. 
2003;Butcher et al. 2005;Kovacs et al. 2004a;Kovacs et al. 2004b). Thus, aberrant resolution 
of inflammation in the geriatric trauma patient could initiate a vicious cycle of DAMP 
release, immune cell stimulation and eventual exhaustion, culminating in more severe 
immunoparesis and an increased susceptibility to infection.      
4.0 Concluding remarks 
Understanding the impact of age on the immune and inflammatory response to traumatic 
injury is an emerging area of research in the field of immune gerontology. Studies have 
shown the geriatric trauma patient elicits an immune response that is distinct to that of the 
younger trauma patient, with evidence of reduced immune cell activation, impaired function 
and abnormal haematopoiesis, which together leave the elderly patient at risk of subsequent 
infection and mortality (Figure 1). Moreover, genomic analysis has revealed age-related 
differences in both the magnitude and duration of the inflammatory response post trauma, 
with the elderly patient initiating an attenuated transcriptomic response in the acute phase, 
which fails to return to a homeostatic baseline in the days following injury, suggesting 
aberrant resolution that would culminate in long-term inflammation and immune suppression. 
Currently, very little is known in respect of the mechanism(s) that underlie the dysregulated 
immune and inflammatory response to trauma in older adults. Our own work suggests that 
age-associated changes in the endocrine system exacerbate trauma-induced changes in the 
circulating levels of immune suppressing and enhancing hormones, culminating in a systemic 
state of immune suppression that is more profound than that witnessed in younger patients 
with similar injuries (Butcher et al. 2005;Butcher and Lord 2004). To our knowledge, this 
observation coupled with the results of a handful of murine-based studies (Kovacs et al. 
2004a;Kovacs et al. 2004b;Nomellini et al. 2008) are the only data that exists that provides a 
potential mechanistic explanation for the altered immune response that accompanies 
traumatic injury in older adults. Results of future studies that address this issue will provide 
much needed information in respect to determining whether targeting certain aspects of the 
immunesenescent profile could serve as a potential therapeutic strategy by which to reduce 
the risk of infection and subsequent mortality in the geriatric trauma patient. 
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Figure Captions 
 
 
Figure 1. Age-associated differences in the innate immune and inflammatory response 
to trauma. Relative to young individuals, older adults elicit a unique immune and 
inflammatory response to traumatic injury. Age-associated immunesenescence and 
inflammaging, driven by elevated levels of circulating DAMPs and a raised cortisol:DHEA 
ratio, are proposed to underlie these changes, which manifest as an exaggerated inflammatory 
response to injury and a greater and more sustained innate immunoparesis. These factors are 
proposed to underlie poor-outcome in the geriatric trauma patient which includes increased 
infection incidence.  Abbreviations: CRP, C-reactive Protein; DAMPs, Damage Associated 
Molecular Patterns; DHEA, Dehydroepiandrosterone; HF, Hip Fracture; HSC, 
Haematopoietic Stem Cell; IL, Interleukin; LoS, Length of Stay; PMN, Polymorphonuclear 
leukocytes; ROS, Reactive Oxygen Species; TNF-α, Tumour Necrosis Factor-Alpha. 
  
Tables 
Table 1. Features of innate and adaptive immunesenescence 
Abbreviations: IL, Interleukin; KLRG1, Killer cell lectin-like receptor subfamily G member 1; LPS, lipopolysaccharide; 
MDSCs, Myeloid Derived Suppressor Cells; NETs, Neutrophil extracellular traps; NKp46, Natural killer cell p46-related 
protein; ROS, Reactive oxygen species; TLR, Toll-like receptor, TNF-α, Tumour-necrosis factor alpha. 
  
Composition 
 
 
Phenotype 
 
Function 
 
References 
 
 
 
 
 
 
Neutrophils 
 
 
 
 
 No change in circulating 
numbers. 
 No change in 
CD11a, CD11b 
expression 
 Reduced chemotaxis 
in vitro. 
 Reduced 
phagocytosis. 
 Impaired NET 
formation. 
 Increased/decreased 
ROS formation. 
 Impaired receptor 
recruitment into lipid 
rafts. 
Hazeldine et al. 
2014; 
 Sapey et al. 2014;  
Tseng et al. 2012;  
Fulop et al.2004; 
Wenisch et al. 2000;  
Born et al 1995. 
 
 
 
 
 
 
Monocytes/ 
Macrophages 
 
 
 
 
 
 No change in circulating 
% and/or absolute 
number. 
 Increased % of CD14+ 
16++ non-classical 
monocytes. 
 Reduced % of CD14+ 
16- classical monocytes. 
 Reduction in 
CD62L, 
TLR1/4 
expression. 
 No change in 
TLR2 
expression. 
 Increase in 
CD11b, TLR5 
expression. 
 Decreased monocyte 
phagocytosis. 
 Decreased LPS-
induced ROS 
production. 
 Increased TLR4-
driven TNF-α 
production. 
 Decreased TLR1/2-
induced production 
of IL-6 and TNF-α. 
 Increased TLR5-
induced IL-8 
production. 
Hearps et al.2012;  
Qian et al. 2012; 
Nyugen et al.2010; 
Seidler et al.2010; 
Van Duin et al.2007; 
McLachlan et 
al.1995  
 
 
 
 
Natural 
killer 
(NK) cells 
 
 
 Increase in CD56DIM % 
and/or number. 
 Reduction in  
CD56BRIGHT % and/or 
number. 
 Increased 
CD56DIM:CD56BRIGHT 
 Comparable 
NKG2D, CD2, 
CD16 
expression. 
 Decreased 
CD94, KLRG1, 
NKp46 
expression. 
 Decreased NKCC. 
 Impaired perforin 
release. 
 Reduced 
cytokine/chemokine 
secretion. 
 Impaired NK cell 
maturation. 
 Impaired 
proliferation in vivo. 
Shehata et al. 2015; 
Hazeldine et al 2012; 
Lutz et al 2011; 
Almedia-Oliveira et 
al.2011; 
Hayhoe et al.2010; 
Lutz et al.2005; 
Mariani et al. 2002; 
Mariani et al.2001 
 
 
MDSCs 
 Increased frequency of 
circulating MDSCs in 
older adults and frail 
elderly. 
 Not known  Not known Verschoor et al. 2013 
